From a molecular pharmacy standpoint, Relafen 750 (Naproxen) presents an noteworthy profile. This nonsteroidal drug primarily functions by blocking the cyclooxygenase catalysts , namely COX-1 and COX-2, which are crucial for the production of eicosanoids. The subsequent decrease in prostaglandin